|Articles|September 1, 2009
- Applied Clinical Trials-09-01-2009
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - September 2009
REGULATORY : Comprehensive Guide for Generic Drug Trials The Unique Concerns of Recombinant DNA Research TRIAL DESIGN : A Crash Course in Adaptive Also in this issue : Sponsors Challenged by Globalization, GCP Inspections Unite EMEA and FDA, Post Credit Crunch R&D Opportunities
Advertisement
Articles in this issue
almost 17 years ago
The Spotlight Falls on Indiaalmost 17 years ago
eClinical Software: September 2009almost 17 years ago
Into the Aftermath of M&Aalmost 17 years ago
EMEA and FDA Team Up on GCPalmost 17 years ago
Does Size Matter in Partnershipsalmost 17 years ago
An Assessment of Adaptivealmost 17 years ago
Business and People Update September 2009almost 17 years ago
eCTD Training Effortsalmost 17 years ago
Global Development Challenges Sponsorsalmost 17 years ago
Regulating the Generic Drug ProcessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5